Moderna Inc. declined to transfer the technology for its COVID-19 vaccine to China due to potential reputational implications if its local partner fails to follow proper manufacturing practices. According to … Read more
A California jury convicted former Theranos executive Sunny Balwani of fraud on July 7 for deceiving investors with former business and romantic partner Elizabeth Holmes at the now-defunct blood-testing company. … Read more
Pfizer and BioNTech said on Monday that three doses of their COVID-19 vaccine produced a strong immune response in children under the age of five in their clinical trial. Pfizer … Read more
Pfizer and BioNech announced on Thursday that a third booster vaccine increases immune defenses against COVID-19 in children ages 5 to 11, particularly against the Omicron variant. Pfizer and BioNTech … Read more
Drugmakers Sanofi and GSK announced on Feb. 23 that they are planning to seek approval from regulators for their COVID-19 vaccine. The companies said data from clinical trials showed that … Read more
New Zealand medicines regulator Medsafe on Feb. 4 granted provisional approval for the Novavax COVID-19 vaccine for people aged 18 years and over. The provisional approval does not mean that … Read more
The United Kingdom on Feb. 3 approved the Novavax COVID-19 vaccine for people over the age of 18. The Medicines and Healthcare products Regulatory Agency (MHRA) granted the vaccine regulatory … Read more
Pfizer and BioNTech on Feb. 1 has requested the United States Food and Drug Administration (FDA) to expand the use of its COVID-19 vaccine to children aged six months to … Read more
Novavax has formally submitted a request for the United States Food and Drug Administration (FDA) to grant emergency use authorization for its COVID-19 vaccine for adults. The vaccine, taken in … Read more
Moderna has started a clinical trial to test its COVID-19 vaccine booster shot specifically targeted against the highly contagious Omicron variant, the company announced on Jan. 26. Moderna said that … Read more